Comparison of platelet parameters in thrombocytopenic patients associated with acute myeloid leukemia and primary immune thrombocytopenia
- 1 April 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 25 (3) , 221-225
Abstract
Thrombocytopenia is caused by insufficient production and excessive destruction of platelets. Recent improvement of automated blood cell analyzers has allowed measurement of several platelet parameters, providing better understanding of the underlying mechanisms of thrombocytopenia. We investigated the significance of platelet parameters in thrombocytopenic patients. Thrombocytopenic patients (platelet 3/μl) who were newly diagnosed with acute myeloid leukemia and primary immune thrombocytopenia were enrolled, and platelet, mean platelet volume, platelet distribution width, platelet crit, mean platelet component, mean platelet mass, and large platelet count were measured, and the percentages of large platelets were calculated. The parameters were also measured in the reference population. The mean values of each parameter were as follows: platelet, 259 × 103/μl; mean platelet volume, 7.9 fl; platelet distribution width, 51.3%; platelet crit, 0.20%; mean platelet component, 26.0 g/dl; mean platelet mass, 1.9 pg; large platelet, 4.7 × 103/μl; large platelet percentage, 1.7%. In comparison with acute myeloid leukemia patients, patients with primary immune thrombocytopenia showed significantly higher mean platelet volume, platelet distribution width, mean platelet component, mean platelet mass, large platelet, and large platelet % (P < 0.05). Because of increased destruction of platelets, primary immune thrombocytopenia patients have increased mean platelet volume, platelet distribution width, mean platelet component, mean platelet mass, large platelet, and large platelet percentage compared with acute myeloid leukemia patients who have ineffective platelet production. Parameters measured by automated analyzer provide better understanding of thrombopoiesis in the bone marrow and the status of the peripheral blood in the clinical field.Keywords
This publication has 17 references indexed in Scilit:
- Reference Intervals for Platelet Parameters in Korean Adults Using ADVIA 2120Annals of Laboratory Medicine, 2013
- Immature platelet count: A simple parameter for distinguishing thrombocytopenia in pediatric acute lymphocytic leukemia from immune thrombocytopeniaPediatric Blood & Cancer, 2010
- Evaluation of Platelet Indices for Differential Diagnosis of Thrombocytosis by ADVIA 120Annals of Laboratory Medicine, 2009
- Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi‐center prospective studyJournal of Thrombosis and Haemostasis, 2006
- Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopeniaBritish Journal of Haematology, 2005
- Chronic thrombocytopenia of childhood: use of non‐invasive methods in clinical evaluationEuropean Journal of Haematology, 2004
- Platelet count and parameters determined by the Bayer ADVIATM 120 in reference subjects and patientsClinical and Laboratory Haematology, 2001
- Improved Platelet Counting Using Two-Dimensional Laser Light ScatterAmerican Journal of Clinical Pathology, 2000
- The determination of a reference range for new platelet parameters produced by the Bayer ADVIATM 120 full blood count analyserClinical and Laboratory Haematology, 2000
- Platelet volume: Laboratory measurement and clinical applicationBlood Reviews, 1993